During the past decade, Latrobe Regional Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Latrobe Regional Hospital" #1 sponsor was "Breast Cancer Trials, Australia and New Zealand" with 1 trials, followed by "Neuroscience Trials Australia" with 1 trials sponsored, "The University of Queensland" with 1 trials sponsored, "University of Melbourne" with 1 trials sponsored and "University of Sydney" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Latrobe Regional Hospital" #1 collaborator was "Applied Health Research Centre" with 1 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Latrobe Regional Hospital" are "Early Stage Breast Carcinoma" (1 trials), "Hyperphosphatemia" (1 trials), "Ischemic Stroke" (1 trials), "Kidney Failure, Chronic" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Latrobe Regional Hospital" in a lesser frequency.

Most popular intervention types in "Latrobe Regional Hospital" are "Drug" (4 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dalteparin" (1 trials), "Darolutamide" (1 trials), "Enoxaparin" (1 trials), "External Beam Radiotherapy" (1 trials) and "Hyperimmune globulin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Latrobe Regional Hospital" are 3 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Latrobe Regional Hospital". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Latrobe Regional Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Latrobe Regional Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".